Colgate-Palmolive
CL
#322
Rank
$74.36 B
Marketcap
$92.01
Share price
1.88%
Change (1 day)
6.95%
Change (1 year)

Colgate-Palmolive Company is an American company specializing in the manufacturing and marketing of cleaning and hygiene products such as detergents, soaps, toothpaste and toothbrushes. The brand is enjoying a strong reputation in many countries.

Colgate-Palmolive - 10-Q quarterly report FY


Text size:
FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended September 30, 2001.

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the transition period from __________ to ___________.

Commission File Number 1-644
-----


COLGATE-PALMOLIVE COMPANY
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)

DELAWARE 13-1815595
- --------------------------------- -----------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)

300 PARK AVENUE, NEW YORK, NEW YORK 10022
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)

(212) 310-2000
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)

NO CHANGES
- --------------------------------------------------------------------------------
(Former name, former address, and former fiscal year, if changed
since last report).

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
--- ------

Indicate the number of shares outstanding of each of the issuers classes of
common stock, as of the latest practical date:

Class Shares Outstanding Date
- ------------------------ ------------------------ -----------------------
Common, $1.00 par value 551,714,856 October 31, 2001

1
PART I.  FINANCIAL INFORMATION
- ------- ---------------------

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
-------------------------------------------

(Dollars in Millions Except Per Share Amounts)
(Unaudited)

- --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
------------- -------------

2001 2000 2001 2000
---- ---- ---- ----
<S> <C> <C> <C> <C>
Net sales $ 2,391.2 $ 2,366.5 $ 7,013.4 $ 6,945.0
Cost of sales 1,072.0 1,073.0 3,155.8 3,159.4
---------- ---------- ----------- -----------
Gross profit 1,319.2 1,293.5 3,857.6 3,785.6

Selling, general and administrative
expenses 843.8 851.9 2,471.1 2,501.4
Interest expense 46.2 54.8 139.5 155.1
Interest income (2.7) (6.5) (9.5) (21.5)
---------- ---------- ----------- -----------

Income before income taxes 431.9 393.3 1,256.5 1,150.6
Provision for income taxes 135.7 118.0 405.2 373.5
---------- ---------- ----------- -----------

Net income $ 296.2 $ 275.3 $ 851.3 $ 777.1
========== ========== =========== ===========

Earnings per common share:

Basic $ .52 $ .47 $ 1.49 $ 1.32
========== ========== =========== ===========

Diluted $ .49 $ .44 $ 1.40 $ 1.24
========== ========== =========== ===========

Dividends declared per common share $ .18 $ .16 $ .50 $ .47
========== ========== =========== ===========
</TABLE>

See Notes to Condensed Consolidated Financial Statements.

2
COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS
-------------------------------------

(Dollars in Millions)
(Unaudited)

- --------------------------------------------------------------------------------

ASSETS
------

September 30, December 31,
2001 2000
------------- ------------

Current assets:
Cash and cash equivalents $ 289.6 $ 206.6
Marketable securities 2.7 5.9
Receivables (net of allowances of
$41.7 and $39.8) 1,146.9 1,195.4
Inventories 725.4 686.6
Other current assets 240.1 252.7
----------- -----------
2,404.7 2,347.2

Property, plant and equipment:
Cost 4,305.3 4,287.3
Less: Accumulated depreciation 1,851.7 1,759.0
----------- -----------
2,453.6 2,528.3

Goodwill and other intangible assets
(net of accumulated amortization
of $702.2 and $651.0) 1,930.0 2,096.4
Other assets 334.5 280.4
----------- -----------
$ 7,122.8 $ 7,252.3
=========== ===========


See Notes to Condensed Consolidated Financial Statements.

3
COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS
-------------------------------------

(Dollars in Millions)
(Unaudited)

- --------------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY
------------------------------------

September 30, December 31,
2001 2000
-------------- --------------

Current liabilities:
Notes and loans payable $ 104.6 $ 121.1
Current portion of long-term debt 358.3 320.2
Accounts payable 665.9 738.9
Accrued income taxes 199.6 163.7
Other accruals 827.5 900.2
---------- ----------
2,155.9 2,244.1

Long-term debt 3,083.3 2,536.9
Deferred income taxes 441.0 447.3
Other liabilities 634.3 555.9

Shareholders' equity:
Preferred stock 343.5 354.1
Common stock 732.9 732.9
Additional paid-in capital 1,109.5 1,144.9
Retained earnings 5,457.3 4,893.7
Accumulated other comprehensive income (1,461.5) (1,269.7)
---------- ----------
6,181.7 5,855.9
Unearned compensation (345.3) (344.4)
Treasury stock, at cost (5,028.1) (4,043.4)
---------- ----------
808.3 1,468.1
---------- ----------
$ 7,122.8 $ 7,252.3
========== ==========


See Notes to Condensed Consolidated Financial Statements.

4
COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
-----------------------------------------------

(Dollars in Millions)

(Unaudited)

- --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
Nine Months Ended
-----------------
September 30,
-------------
2001 2000
----------- -----------
<S> <C> <C>
Operating Activities:
- ---------------------
Net income $ 851.3 $ 777.1
Adjustments to reconcile net income to net cash
provided by operations:
Restructured operations (3.8) (6.1)
Depreciation and amortization 250.2 252.3
Income taxes and other, net 120.9 120.2
Cash effects of changes in:
Receivables 27.8 (98.8)
Inventories (64.2) 5.1
Payables and accruals (84.4) 32.0
---------- -----------
Net cash provided by operating activities 1,097.8 1,081.8

Investing Activities:
- ---------------------
Capital expenditures (199.5) (236.7)
Payments for acquisitions, net of cash acquired (10.2) (49.5)
Proceeds from sale of marketable securities 2.1 22.9
Proceeds from sale of long-term investments 4.6 106.4
Other (50.5) (7.2)
---------- -----------
Net cash used for investing activities (253.5) (164.1)

Financing Activities:
- ---------------------
Principal payments on debt (195.8) (660.2)
Proceeds from issuance of debt 762.1 832.2
Payments to outside investors - (113.9)
Purchase of common stock (1,059.2) (704.0)
Dividends paid (287.7) (283.3)
Other 21.0 29.0
---------- -----------
Net cash used for financing activities (759.6) (900.2)

Effect of exchange rate changes on
cash and cash equivalents (1.7) (6.2)
---------- -----------
Net increase in cash and cash equivalents 83.0 11.3

Cash and cash equivalents at beginning of period 206.6 199.6
---------- -----------
Cash and cash equivalents at end of period $ 289.6 $ 210.9
========== ==========
</TABLE>


See Notes to Condensed Consolidated Financial Statements.

5
COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
----------------------------------------------------

(Dollars and Shares in Millions Except Per Share Amounts)
(Unaudited)

- --------------------------------------------------------------------------------

1. The Condensed Consolidated Financial Statements reflect all normal
recurring adjustments which, in management's opinion, are necessary for a
fair presentation of the results for interim periods. Results of operations
for the interim periods may not be representative of results to be expected
for a full year.

2. Provision for certain expenses, including income taxes, media advertising,
consumer promotion and new product introductory costs, are based on full
year assumptions. Such expenses are charged to operations in the year
incurred and are included in the accompanying condensed consolidated
financial statements in proportion with the passage of time or with
estimated annual tax rates or annual sales.

3. Inventories by major classes were as follows:

September 30, December 31,
2001 2000
--------------- ------------

Raw materials and supplies $ 190.7 $ 206.2
Work-in-process 32.1 30.7
Finished goods 502.6 449.7
--------- ---------
$ 725.4 $ 686.6
========= =========

4. Earnings Per Share:

<TABLE>
<CAPTION>
Three Months Ended
------------------
September 30, 2001 September 30, 2000
-------------------------------- --------------------------------
Per Per
Income Shares Share Income Shares Share
------ ------ ----- ------ ------ -----
<S> <C> <C> <C> <C> <C> <C>
Net income $ 296.2 $ 275.3
Preferred dividends (5.8) (5.2)
-------- --------

Basic EPS 290.4 554.5 $.52 270.1 573.6 $.47
==== ====

Stock options 8.4 8.9
ESOP conversion 5.7 40.9 4.9 42.4
-------- ----- -------- ------

Diluted EPS $ 296.1 603.8 $.49 $ 275.0 624.9 $.44
======== ===== ==== ======== ====== ====
</TABLE>

6
COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
----------------------------------------------------

(Dollars and Shares in Millions Except Per Share Amounts)
(Unaudited)

- --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
Nine Months Ended
-----------------

September 30, 2001 September 30, 2000
------------------------------- -------------------------------
Per Per
Income Shares Share Income Shares Share
------ ------ ----- ------ ------ -----
<S> <C> <C> <C> <C> <C> <C>
Net income $ 851.3 $ 777.1
Preferred dividends (15.9) (15.6)
-------- --------

Basic EPS 835.4 559.9 $1.49 761.5 576.1 $1.32
===== =====

Stock options 8.9 10.0
ESOP conversion 15.6 41.2 18.3 42.8
-------- ------ -------- ------

Diluted EPS $ 851.0 610.0 $1.40 $ 779.8 628.9 $1.24
======== ====== ===== ======== ====== =====
</TABLE>


5. Comprehensive income

Comprehensive income is comprised of net earnings, currency translation
gains and losses, and gains and losses from derivative instruments
designated as cash flow hedges. Total comprehensive income for the three
months ended September 30, 2001 and 2000 was $178.7 and $248.4,
respectively. Total comprehensive income for the nine months ended
September 30, 2001 and 2000 was $659.5 and $696.6, respectively. The
difference from net income primarily consists of foreign currency
translation. Comprehensive income in 2001 includes a charge to cumulative
translation adjustment resulting from the devaluation of the Brazilian real
which was, in effect, a write-down of foreign-currency denominated assets
(primarily goodwill and property, plant and equipment). This will be
accompanied by lower amortization and depreciation expense in future
periods. Accumulated other comprehensive income, as reflected in the
condensed consolidated balance sheets, primarily consists of cumulative
foreign currency translation adjustments.

7
COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
----------------------------------------------------

(Dollars in Millions Except Per Share Amounts)
(Unaudited)

- --------------------------------------------------------------------------------


6. Segment Information -

<TABLE>
<CAPTION>
Three months ended Nine months ended
September 30, September 30,
2001 2000 2001 2000
------------ ------------ ------------ -----------
<S> <C> <C> <C> <C>
Net Sales
North America $ 617.4 $ 597.5 $ 1,782.1 $ 1,712.8
Latin America 617.8 620.9 1,816.0 1,845.1
Europe 483.6 483.8 1,419.4 1,426.2
Asia/Africa 380.8 396.6 1,139.0 1,150.9
----------- ----------- ----------- -----------
Total Oral, Personal and
Household Care 2,099.6 2,098.8 6,156.5 6,135.0
Total Pet Nutrition 291.6 267.7 856.9 810.0
----------- ----------- ----------- -----------
Net Sales $ 2,391.2 $ 2,366.5 $ 7,013.4 $ 6,945.0
=========== =========== =========== ===========

Earnings
North America $ 133.8 $ 125.1 $ 396.4 $ 366.7
Latin America 175.0 151.7 498.3 437.4
Europe 88.0 82.8 259.9 250.0
Asia/Africa 44.0 51.0 148.7 144.6
----------- ----------- ----------- -----------
Total Oral, Personal and
Household Care 440.8 410.6 1,303.3 1,198.7
Total Pet Nutrition 68.7 61.4 206.3 175.0
Corporate overhead and other (34.1) (30.4) (123.1) (89.5)
----------- ----------- ----------- -----------
Earnings before interest and
taxes 475.4 441.6 1,386.5 1,284.2
Interest expense, net (43.5) (48.3) (130.0) (133.6)
----------- ----------- ----------- -----------
Income before income taxes $ 431.9 $ 393.3 $ 1,256.5 $ 1,150.6
=========== =========== =========== ===========
</TABLE>

8
COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
----------------------------------------------------

(Dollars in Millions Except Per Share Amounts)
(Unaudited)

- --------------------------------------------------------------------------------


7. New Accounting Pronouncements

In April 2001, the Financial Accounting Standards Board's (FASB) Emerging
Issues Task Force (EITF) reached a consensus on Issue No. 00-25, "Vendor
Income Statement Characterization of Consideration Paid to a Reseller of
the Vendor's Products." This issue addresses the income statement
classification of consideration from a vendor to a customer in connection
with the customer's purchase or promotion of the vendor's products. This
consensus is expected to impact only revenue and expense classifications
and not to change reported net income. At the same meeting, the EITF also
deferred the effective date of Issue No. 00-14, "Accounting for Certain
Sales Incentives," the impact of which was disclosed in Note 2 to the
consolidated financial statements included in the Company's Annual Report
on Form 10-K for the year ended December 31, 2000, to coincide with the
adoption of Issue No. 00-25. In accordance with the consensuses reached,
the Company will adopt the accounting required by Issue No. 00-14 and Issue
No. 00-25 effective January 1, 2002.

In July 2001, the FASB issued Statement of Financial Accounting Standards
(SFAS) No. 141 "Business Combinations" and SFAS No. 142 "Goodwill and Other
Intangible Assets." In addition to requiring the use of the purchase method
for all future business combinations, SFAS 141 broadens the criteria for
recording intangible assets separate from goodwill. SFAS 142 addresses
accounting and reporting standards for acquired goodwill and other
intangible assets. Under the new standards, goodwill and indefinite life
intangible assets are no longer amortized but will be subject to annual
impairment tests. Finite life intangible assets will continue to be
amortized over their useful lives.

The Company will adopt these statements effective January 1, 2002. The
provisions to cease amortization of goodwill and indefinite life intangible
assets are expected to increase net income, however, the Company is still
quantifying the impact. Annual amortization expense related to goodwill and
other intangible assets was $72 million in 2000 and is estimated to be
approximately $69 million for 2001. During 2002, the Company will perform
the required impairment tests of goodwill and indefinite life intangible
assets as of January 1, 2002. It is management's preliminary assessment
that an impairment charge, if any, upon adoption of SFAS 141 and 142 will
not be material.

8. Reference is made to the Company's Annual Report on Form 10-K filed with
the Securities and Exchange Commission for the year ended December 31, 2000
for a complete set of financial notes including the Company's significant
accounting policies.

9
COLGATE-PALMOLIVE COMPANY

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
-------------------------------------------------
CONDITION AND RESULTS OF OPERATIONS
-----------------------------------


(Dollars in Millions Except Per Share Amounts)

- --------------------------------------------------------------------------------

Results of Operations
- ---------------------

Worldwide sales reached $2,391.2 in the third quarter of 2001. Sales increased
2.0%, excluding divestments, as compared to the 2000 third quarter, reflecting
unit volume gains of 5.5% offset by a decline in foreign currencies. Sales would
have risen 5.0%, excluding the effect of foreign currency declines.

Third quarter sales in the Oral, Personal and Household Care segment, excluding
divestments, were $2,099.6, up 1.0% from 2000 on volume growth of 5.0% offset by
foreign currencies.

Colgate-North America sales grew 3.5% in the third quarter of 2001 to $617.4 on
volume gains of 4.5%. Volume increases were attributable to the continued
success of products in the Oral Care category such as Colgate Total plus
Whitening toothpaste, Colgate 2in1 liquid toothpaste and mouthwash and the
battery-powered Colgate Actibrush toothbrush. In the Personal Care category, the
Softsoap Fruit Essentials and Softsoap Vitamins with Vitamin E shower gels and
liquid hand soaps contributed to increased volume and market shares as well.

Colgate-Latin America sales increased 2.5% to $617.8 on volume gains of 7.5%,
excluding divested businesses. Strong volume growth was seen in Mexico, Brazil,
Colombia, Ecuador and Central America. The continued success of products such as
Colgate Herbal and Colgate Triple Action toothpastes contributed to increased
sales in the Oral Care category. In the Personal Care category, products such as
Protex cream, Lady Speed Stick Dry Cream and Palmolive Kids bar soap contributed
to volume gains. New products such as Fabuloso Paraiso Tropical liquid cleaner
and Suavitel Apple Blossom scent fabric softener helped to increase sales and
volume in the Household Surface Care category.

Colgate-Europe sales, excluding divestments, increased slightly to $483.6 as
volume gains of 4.0% were negatively impacted by foreign currency. Excluding the
impact of foreign currency, sales would have risen 4.0% largely due to volume
increases in Italy, the United Kingdom, Spain, Switzerland, Greece and Russia.
Oral Care market share growth within the region was generated by new
introductions including the Colgate Total Plus Whitening and Colgate Herbal
toothpastes. Contributing to growth in the Personal Care category were products
such as Palmolive Vitamins with Vitamin E liquid hand soap and shower gel and
Palmolive Aroma Therapy shower gel and bath foam. Recently introduced products
such as Ajax Antibacterial All Purpose Cleaner wipes and Ajax Glass wipes helped
to increase shares in the Household Surface Care category.

Colgate-Asia/Africa third quarter sales decreased 4.0% to $380.8 as volume gains
of 4.0% were negatively impacted by foreign currencies. Volume growth was driven
primarily by China, Malaysia, Australia and South Africa and was partially
offset by volume declines in certain countries in Africa and the Middle East.
Leadership in the Oral Care category strengthened throughout Asia, especially in
China, driven by the success of products such as Colgate Herbal and Colgate
Fresh Confidence toothpastes and Colgate Premier Ultra and Colgate Navigator
toothbrushes. The region also experienced volume growth from new products such
as Axion Spring Fresh dishwashing liquid and the Palmolive Fruit Essentials line
of bar soap, liquid hand soap and shower gels.

Hill's Pet Nutrition sales increased 9.0% to $291.6 on unit volume gains of
8.0%. Hill's strengthened its domestic leadership in the specialty retail
channel through effective in-store displays, strong advertising support and
innovative new products such as Science Diet Oral Care, Science Diet Canine
Small Bites Lite and Prescription Diet z/d anti-allergy formula.
Hill's-International achieved strong volume growth across Europe, Latin America
and Asia/South Pacific driven by successful new products including Science Diet
Canine and Feline Sensitive Skin/Sensitive Stomach and Science Diet Feline Oral
Care.

10
COLGATE-PALMOLIVE COMPANY

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
-------------------------------------------------
CONDITION AND RESULTS OF OPERATIONS
-----------------------------------

(Dollars in Millions Except Per Share Amounts)

- --------------------------------------------------------------------------------

Sales in the Oral, Personal and Household Care segment, excluding divestments,
for the nine months ended September 30, 2001 were $6,156.5, up 1.5% from the
comparable period in 2000 as volume rose 5.5% partially offset by a decline in
foreign currencies. Within this segment, Colgate-North America sales increased
4.0% on volume growth of 5.0%, Colgate-Latin America sales, excluding divested
businesses, increased 1.5% on volume growth of 5.5%, Colgate-Europe sales,
excluding divested businesses, slightly decreased on volume growth of 5.5% and
Colgate-Asia/Africa sales decreased 1.0% on volume growth of 7.0%.

Worldwide gross profit margin for the third quarter of 2001 increased to 55.2%
from 54.7% in 2000 as the Company continued to benefit from streamlining
manufacturing costs, global sourcing and other cost reduction programs. Gross
profit margin for the first nine months of 2001 increased to 55.0% from 54.5% in
2000.

Selling, general and administrative expenses as a percentage of sales decreased
to 35.3% in the third quarter of 2001 from 36.0% in 2000, and decreased to 35.2%
in the first nine months of 2001 from 36.0% for the comparable period in 2000,
as a result of continued efficiencies and the impact of translation on local
currency advertising costs. Additionally, some promotion spending (i.e.
"360-degree advertising") has been shifted to programs that are reported as a
reduction of sales.

Earnings before interest and taxes (EBIT) increased 8% to $475.4 in the 2001
third quarter, and reached a level of 19.9% of sales versus 18.7% in the third
quarter of 2000. For the first nine months of 2001 EBIT increased 8% to
$1,386.5, a level of 19.8% of sales as compared to 18.5% in 2000.

Interest expense, net of interest income, decreased to $43.5 in the 2001 third
quarter as compared with $48.3 in 2000. For the first nine months of 2001,
interest expense decreased to $130.0 as compared with $133.6 in 2000, primarily
due to the effect of lower interest rates partially offset by higher debt levels
in 2001.

The effective tax rate for the third quarter of 2001 was 31.4% compared to 30.0%
in the third quarter of 2000. The effective rate for the first nine months of
2001 was 32.2% versus 32.5% for the same period in 2000. The 32.2% rate reflects
the Company's current estimate of its full year effective income tax rate which
is slightly higher than the 2000 full year rate of 32.1%.

Net income for the third quarter of 2001 increased 8% to $296.2 or $0.49 per
share on a diluted basis compared with $275.3 or $0.44 per share in the prior
year. For the first nine months of 2001, net income increased 10% to $851.3 or
$1.40 per share on a diluted basis compared with $777.1 or $1.24 per share in
the prior year.

Liquidity and Capital Resources
- -------------------------------

Net cash provided by operations increased 1% to $1,097.8 in the first nine
months of 2001 compared with $1,081.8 in the comparable period of 2000. Net cash
from operations includes a non-recurring first quarter tax payment related to
the sale of the Viva detergent brand in Mexico that occurred in the fourth
quarter of 2000. Excluding the effect of this tax payment, net cash provided by
operations increased by 4% over the prior period. At September 30, 2001, $716.5
of commercial paper was classified as long-term debt in accordance with the
Company's intent and ability to refinance these obligations on a long-term
basis.

Reference should be made to the Company's Annual Report on Form 10-K for the
year ended December 31, 2000 for additional information regarding liquidity and
capital resources.

11
PART II.  OTHER INFORMATION
- -------- -----------------

- --------------------------------------------------------------------------------


Item 1. Legal Proceedings
- ------- -----------------

For information regarding legal matters refer to Item 3 on page 4 of
the registrant's Annual Report on Form 10-K for the year ended
December 31, 2000 and Note 14 to the consolidated financial statements
included therein on pages 36-37.

Item 6. Exhibits and Reports on Form 8-K
- ------- --------------------------------

(a) Exhibits:

Exhibit 12 Ratio of Earnings to Fixed Charges.

(b) Reports on Form 8-K.

None.


The exhibits indicated above which are not included with the Form 10-Q are
available upon request and payment of a reasonable fee approximating the
registrant's cost of providing and mailing the exhibits. Inquiries should be
directed to:

Colgate-Palmolive Company
Office of the Secretary (10-Q Exhibits)
300 Park Avenue
New York, NY 10022-7499

12
SIGNATURE
---------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

COLGATE-PALMOLIVE COMPANY
-------------------------
(Registrant)



Principal Financial Officer:

November 9, 2001 /s/ Stephen C. Patrick
----------------------------------
Stephen C. Patrick
Chief Financial Officer

Principal Accounting Officer:

November 9, 2001 /s/ Dennis J. Hickey
----------------------------------
Dennis J. Hickey
Vice President and
Corporate Controller

13